. 2021 Oct 7;3(4):otab071. doi: 10.1093/crocol/otab071
© The Author(s) 2021. Published by Oxford University Press on behalf of Crohn\'s & Colitis Foundation.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Figure 1.
Infliximab dose rounding practices of surveyed gastroenterologists (n = 47).